SMLR Stock Price, Semler Scientific, Inc. Quote, Chart

Market Summary

USD26.62-0.47

Market Closed

-1.73%

SMLR Stock Price

View Fullscreen

SMLR RSI Chart

SMLR Valuation

Market Cap

190.5M

Price/Earnings (Trailing)

9.25

Price/Sales (Trailing)

2.79

EV/EBITDA

5.4

Price/Free Cashflow

9.08

SMLR Price/Sales (Trailing)

SMLR Profitability

Operating Margin

89.76%

EBT Margin

35.35%

Return on Equity

28.67%

Return on Assets

26.37%

Free Cashflow Yield

11.02%

SMLR Fundamentals

SMLR Revenue

Revenue (TTM)

68.2M

Rev. Growth (Yr)

9.15%

Rev. Growth (Qtr)

-7.72%

SMLR Earnings

Earnings (TTM)

20.6M

Earnings Growth (Yr)

31.25%

Earnings Growth (Qtr)

-23.45%

Breaking Down SMLR Revenue

Last 7 days

4.2%

Last 30 days

-9.7%

Last 90 days

-38.5%

Trailing 12 Months

-2.3%

How does SMLR drawdown profile look like?

SMLR Financial Health

Current Ratio

10.64

SMLR Investor Care

Shares Dilution (1Y)

0.49%

Diluted EPS (TTM)

2.63

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	60.9M	64.7M	66.9M	68.2M
2022	53.9M	54.4M	54.4M	56.7M
2021	42.4M	50.3M	53.6M	53.0M
2020	35.4M	33.9M	35.7M	38.6M
2019	23.8M	26.3M	29.6M	32.8M
2018	14.9M	17.8M	19.7M	21.5M
2017	8.0M	8.9M	10.6M	12.5M
2016	7.3M	7.6M	8.1M	7.4M
2015	4.0M	4.5M	5.1M	7.0M
2014	2.7M	3.1M	3.4M	3.6M
2013	0	0	0	2.3M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Semler Scientific, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Sep 13, 2023	semler eric	bought	755,260	28.11	26,868	-
Sep 12, 2023	semler eric	bought	717,513	27.7	25,903	-
Sep 11, 2023	semler eric	bought	674,500	26.98	25,000	-
May 31, 2023	messina daniel s	acquired	-	-	909	-
Feb 01, 2023	messina daniel s	acquired	-	-	3,045	-
Feb 01, 2023	pan wayne t	acquired	-	-	2,436	-
Feb 01, 2023	leibowitz arthur n	acquired	-	-	2,436	-
Feb 01, 2023	moon cindy	acquired	-	-	2,436	-
Feb 01, 2023	moon cindy	sold (taxes)	-43,964	41.05	-1,071	-
Nov 04, 2022	william h.c. chang & diana shon chang ttee chang family trust u/a dtd 10/23/2006	gifted	-	-	-105,582	-

Which funds bought or sold SMLR recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	Legal Advantage Investments, Inc.	unchanged	-	-335,063	649,017	0.36%
Apr 23, 2024	AMALGAMATED BANK	reduced	-76.13	-26,000	5,000	-%
Apr 22, 2024	MetLife Investment Management, LLC	unchanged	-	54,585	127,777	-%
Apr 19, 2024	Veery Capital, LLC	sold off	-100	-265,740	-	-%
Apr 19, 2024	DENALI ADVISORS LLC	unchanged	-	-218,660	423,545	0.12%
Apr 18, 2024	Allspring Global Investments Holdings, LLC	reduced	-55.98	-1,840,680	752,946	-%
Apr 16, 2024	Financial Management Professionals, Inc.	reduced	-55.23	-80,000	33,000	-%
Apr 16, 2024	TOTH FINANCIAL ADVISORY CORP	unchanged	-	-3,016	5,842	-%
Apr 15, 2024	EXCHANGE TRADED CONCEPTS, LLC	added	32.98	-47,136	336,061	0.01%
Apr 05, 2024	CWM, LLC	new	-	4,000	4,000	-%

Are Funds Buying or Selling SMLR?

Are funds buying SMLR calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own SMLR

No. of Funds

Unveiling Semler Scientific, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 12, 2024	topline capital management, llc	0%	0	SC 13G/A
Jan 26, 2024	altravue capital, llc	1.%	0	SC 13G/A
Sep 14, 2023	semler eric	9.4%	645,992	SC 13D/A
May 17, 2023	murphy-chutorian douglas	10.32%	784,571	SC 13D/A
Apr 20, 2023	semler eric	8.3%	568,221	SC 13D/A
Apr 20, 2023	william h.c. chang & diana shon chang ttee chang family trust u/a dtd 10/23/2006	9.38%	641,991	SC 13D/A
Feb 15, 2023	topline capital management, llc	5.8%	399,860	SC 13G
Feb 14, 2023	park west asset management llc	0%	0	SC 13G/A
Jan 19, 2023	altravue capital, llc	6.39%	437,277	SC 13G/A
Jan 05, 2023	william h.c. chang & diana shon chang ttee chang family trust u/a dtd 10/23/2006	9.38%	641,991	SC 13D/A

Recent SEC filings of Semler Scientific, Inc.

View All Filings

Date Filed	Form Type	Document
Mar 07, 2024	10-K	Annual Report
Mar 05, 2024	8-K	Current Report
Feb 12, 2024	SC 13G/A	Major Ownership Report
Jan 26, 2024	SC 13G/A	Major Ownership Report
Jan 22, 2024	8-K	Current Report

Peers (Alternatives to Semler Scientific, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	185.5B	40.1B	-2.69%	-2.54%	32.41	4.63	-8.12%	-17.45%
BDX	67.5B	19.5B	-4.86%	-10.59%	53.77	3.46	4.02%	-22.04%
ALGN	23.6B	3.9B	-2.36%	-14.10%	52.95	6.1	3.42%	23.09%
BAX	20.8B	14.8B	-2.22%	-9.67%	7.83	1.4	2.12%	209.17%
MID-CAP
HSIC	9.4B	12.3B	-0.49%	-14.47%	22.62	0.76	-2.44%	-22.68%
ATR	9.3B	3.5B	-1.02%	16.40%	32.52	2.65	4.97%	18.89%
BIO	8.1B	2.7B	-18.63%	-38.25%	-12.74	3.04	-4.68%	82.43%
XRAY	6.4B	4.0B	-5.77%	-25.53%	-47.67	1.62	1.10%	85.84%
AXNX	3.4B	366.4M	-2.62%	10.65%	-558.61	9.25	33.86%	89.83%
PDCO	2.3B	6.6B	-4.73%	-4.84%	12.02	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-11.22%	-19.13%	-1.92	0.41	7.73%	-1066.14%
ANIK	383.0M	166.7M	1.30%	-3.37%	-4.63	2.3	6.67%	-456.34%
ANGO	241.5M	324.0M	12.50%	-31.24%	-1.26	0.75	-3.19%	-337.41%
APYX	45.7M	52.3M	5.60%	-56.15%	-2.44	0.87	17.61%	19.28%
AEMD	4.0M	3.7M	-11.70%	184.91%	-0.32	1.06	5.77%	8.23%

Semler Scientific, Inc. News

Latest updates

Semler Scientific, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	-7.7%	15.00	16.00	19.00	18.00	14.00	14.00	15.00	14.00	12.00	14.00	14.00	13.00	12.00	11.00	6.00	9.00	9.00	9.00	8.00	7.00	6.00
Cost Of Revenue	204.7%	3.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	2.00	1.00	1.00	2.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Costs and Expenses	25.1%	13.00	10.00	11.00	12.00	10.00	10.00	10.00	10.00	10.00	9.00	8.00	7.00	6.00	5.00	5.00	6.00	6.00	6.00	5.00	5.00	-
Operating Expenses	2.8%	1.00	1.00	2.00	2.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	-2.73
S&GA Expenses	32.8%	5.00	3.00	5.00	5.00	5.00	4.00	4.00	5.00	4.00	4.00	4.00	3.00	3.00	2.00	2.00	3.00	2.00	2.00	2.00	2.00	2.00
EBITDA Margin	-13.2%	0.36*	0.42*	0.39*	0.36*	0.33*	0.30*	0.31*	0.33*	0.38*	0.46*	0.50*	0.46*	0.44*	-	-	-	-	-	-	-	-
Interest Expenses	-100.0%	-	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	-	-0.10
Income Taxes	-195.5%	-1.41	1.00	2.00	2.00	1.00	1.00	1.00	1.00	0.00	1.00	-0.21	1.00	1.00	1.00	-0.08	1.00	0.00	-4.67	0.00	-	-
Earnings Before Taxes	-59.7%	3.00	7.00	8.00	7.00	4.00	5.00	5.00	4.00	2.00	5.00	6.00	6.00	6.00	6.00	1.00	3.00	3.00	3.00	3.00	2.00	1.00
EBT Margin	-6.3%	0.35*	0.38*	0.35*	0.33*	0.31*	0.28*	0.30*	0.32*	0.37*	0.45*	0.49*	0.45*	0.43*	-	-	-	-	-	-	-	-
Net Income	-23.4%	4.00	6.00	6.00	5.00	3.00	4.00	4.00	3.00	2.00	4.00	7.00	5.00	5.00	5.00	1.00	3.00	3.00	8.00	3.00	2.00	1.00
Net Income Margin	3.2%	0.30*	0.29*	0.27*	0.26*	0.25*	0.23*	0.24*	0.29*	0.32*	0.39*	0.43*	0.38*	0.36*	-	-	-	-	-	-	-	-
Free Cashflow	-7.8%	4.00	5.00	11.00	1.00	2.00	8.00	6.00	1.00	2.00	8.00	2.00	4.00	6.00	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-1.7%	78.00	79.00	75.00	70.00	63.00	61.00	58.00	55.00	51.00	51.00	46.00	41.00	35.00	28.00	21.00	20.00	18.00	19.00	10.00	9.00	8.00
Current Assets	2.4%	66.00	64.00	61.00	56.00	49.00	52.00	49.00	50.00	46.00	46.00	41.00	33.00	27.00	22.00	15.00	13.00	11.00	12.00	8.00	7.00	6.00
Cash Equivalents	52.5%	57.00	37.00	39.00	5.00	23.00	46.00	40.00	38.00	37.00	36.00	29.00	26.00	22.00	17.00	14.00	11.00	8.00	9.00	4.00	5.00	3.00
Inventory	1.4%	0.00	0.00	0.00	1.00	0.00	1.00	1.00	1.00	1.00	2.00	2.00	1.00	0.00	-	-	-	-	-	-	-	-
Net PPE	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	-27.7%	6.00	9.00	10.00	9.00	7.00	8.00	7.00	6.00	5.00	7.00	6.00	5.00	5.00	6.00	4.00	4.00	5.00	5.00	4.00	3.00	4.00
Shareholder's Equity	1.4%	72.00	71.00	65.00	61.00	56.00	52.00	51.00	49.00	46.00	44.00	40.00	35.00	30.00	22.00	17.00	16.00	13.00	14.00	6.00	6.00	4.00
Retained Earnings	7.6%	60.00	56.00	50.00	44.00	39.00	36.00	32.00	28.00	25.00	23.00	19.00	13.00	8.00	2.00	-2.59	-3.66	-6.33	-9.17	-16.95	-19.56	-21.42
Additional Paid-In Capital	-21.1%	12.00	15.00	15.00	17.00	16.00	16.00	18.00	21.00	21.00	21.00	21.00	23.00	22.00	20.00	20.00	19.00	19.00	23.00	23.00	26.00	26.00
Shares Outstanding	2.3%	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	115	-	-	-	155	-	-	-	472	-	-	-	193	-	-	-	171	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	-8.1%	4,442	4,831	11,196	861	1,710	8,021	6,230	1,502	1,657	7,637	2,156	4,606	5,546	3,510	2,355	3,703	3,635	4,710	2,680	1,703	2,046
Share Based Compensation	-21.3%	37.00	47.00	158	702	33.00	32.00	48.00	628	67.00	47.00	46.00	589	63.00	62.00	61.00	67.00	83.00	86.00	98.00	98.00	131
Cashflow From Investing	374.8%	18,629	-6,778	24,969	-18,424	-24,307	-491	-1,781	-256	-223	-227	-159	-216	-316	-467	10.00	-233	-490	-366	-386	-456	-390
Cashflow From Financing	-6245.1%	-3,236	-51.00	-1,975	-146	75.00	-2,025	-2,844	-143	-41.00	9.00	36.00	9.00	56.00	104	67.00	3.00	-3,946	16.00	-2,656	13.00	-1,459
Buy Backs	-	-	-	-	-	-	2,046	2,846	99.00	-	-	-	-	-	-	-	-	-	-	-	-	-

SMLR Income Statement

2023-12-31

Statements of Income - USD ($) $ in Thousands	12 Months Ended
Statements of Income - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Statements of Income
Revenues	$ 68,184	$ 56,686
Operating expenses:
Cost of revenues	6,984	4,252
Engineering and product development	5,773	4,809
Sales and marketing	18,147	17,685
General and administrative	14,290	12,737
Strategic streamlining	734
Total operating expenses	45,928	39,483
Income from operations	22,256	17,203
Interest and dividend income	2,471	494
Impairment of investments	(337)
Change in fair value of notes held for investment	(307)
Other income (expenses)	17	(5)
Other income, net	1,844	489
Pre-tax income	24,100	17,692
Income tax provision	3,517	3,367
Net income	$ 20,583	$ 14,325
Net income per share, basic	$ 3.06	$ 2.13
Weighted average number of shares used in computing basic net income per share	6,732,806	6,726,687
Net income per share, diluted	$ 2.63	$ 1.79
Weighted average number of shares used in computing diluted net income per share	7,819,159	7,999,750

SMLR Balance Sheet

2023-12-31

Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current Assets:
Cash and cash equivalents	$ 57,200	$ 23,014
Restricted cash	132
Short-term investments		20,073
Trade accounts receivable, net of allowance for credit losses of $287 and $109, respectively	6,125	3,884
Inventory, net	445	469
Prepaid expenses and other current assets	2,042	1,468
Total current assets	65,944	48,908
Assets for lease, net	2,285	2,478
Property and equipment, net	720	667
Long-term investments	512	821
Notes held for investment (includes measured at fair value of $4,372 and $3,679, respectively)	5,372	4,679
Other non-current assets	270	2,842
Deferred tax assets	2,962	2,298
Total assets	78,065	62,693
Current liabilities:
Accounts payable	402	835
Accrued expenses	4,502	4,748
Deferred revenue	1,120	1,160
Other short-term liabilities	176	114
Total current liabilities	6,200	6,857
Long-term liabilities:
Other long-term liabilities	70	160
Total long-term liabilities	70	160
Commitments and contingencies (Note 13)
Stockholders' equity:
Common stock, $0.001 par value; 50,000,000 shares authorized; 7,099,441 and 6,906,544 shares issued, and 6,885,019 and 6,692,122 shares outstanding (treasury shares of 214,422 and 214,422), respectively	7	7
Additional paid-in capital	11,985	16,449
Retained earnings	59,803	39,220
Total stockholders' equity	71,795	55,676
Total liabilities and stockholders' equity	$ 78,065	$ 62,693

About Semler Scientific, Inc.

Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups, long-term care, or remote patient monitoring organizations. It offers its products through salespersons and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

CEO	Dr. Douglas Murphy-Chutorian M.D.
WEBSITE	semlerscientific.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	127

Semler Scientific, Inc. Frequently Asked Questions

What is the ticker symbol for Semler Scientific, Inc.? What does SMLR stand for in stocks?

SMLR is the stock ticker symbol of Semler Scientific, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Semler Scientific, Inc. (SMLR)?

As of Tue Apr 23 2024, market cap of Semler Scientific, Inc. is 190.47 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SMLR stock?

You can check SMLR's fair value in chart for subscribers.

What is the fair value of SMLR stock?

You can check SMLR's fair value in chart for subscribers. The fair value of Semler Scientific, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Semler Scientific, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SMLR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Semler Scientific, Inc. a good stock to buy?

The fair value guage provides a quick view whether SMLR is over valued or under valued. Whether Semler Scientific, Inc. is cheap or expensive depends on the assumptions which impact Semler Scientific, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SMLR.

What is Semler Scientific, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, SMLR's PE ratio (Price to Earnings) is 9.25 and Price to Sales (PS) ratio is 2.79. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SMLR PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Semler Scientific, Inc.'s stock?

In the past 10 years, Semler Scientific, Inc. has provided 0.184 (multiply by 100 for percentage) rate of return.